Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction

Sentiment:

SEC Form 4 Filing


CFO and Treasurer of Fulgent Genetics, Paul Kim, reports disposition of shares to cover tax obligations arising from vesting of restricted stock units.

Summary

  • On April 26, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported a transaction involving the disposition of 2,738 shares of common stock.
  • The shares were withheld to satisfy tax withholding obligations related to the vesting of restricted stock units granted on November 7, 2022.
  • The transaction price was $20.1 per share.
  • Following the transaction, Kim directly owns 219,672 shares of Fulgent Genetics.

Sentiment

Score: 5

Explanation: The document reports a routine transaction related to tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common occurrence when restricted stock units vest.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it is a routine tax-related stock disposition.

Key Dates

DateDescription
November 7, 2022Date of grant of restricted stock units that led to the tax obligation.
November 9, 2022Original report on Form 4 filed with the U.S. Securities and Exchange Commission.
April 26, 2024Date of the stock transaction (disposition of shares for tax withholding).
April 30, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.